SCHEDULE: Intracoastal Capital Discloses 4.99% Stake in Iveda Solutions
Beneficial Ownership Report
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 4.99% beneficial ownership stake in Iveda Solutions, Inc. common stock.
Summary
- Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") beneficially own 592,195 shares of Iveda Solutions, Inc. Common Stock.
- This ownership represents 4.99% of the company's outstanding Common Stock as of the close of business on February 13, 2026.
- The beneficial ownership primarily stems from shares issuable upon the exercise of Intracoastal Warrant 2.
- The Reporting Persons' stake is a result of a Securities Purchase Agreement (SPA) executed with Iveda Solutions, Inc. on February 9, 2026.
- Warrants held by Intracoastal Capital LLC (Intracoastal Warrant 1, 2, and 3) include blocker provisions that prevent beneficial ownership from exceeding 9.99% or 4.99% of the Common Stock.
- Without these blocker provisions, the Reporting Persons would have been deemed to beneficially own 1,577,868 shares of Common Stock as of February 13, 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, as a new institutional investor has taken a significant stake, indicating confidence. However, the passive nature and blocker provisions limit immediate impact on control or strategy.
Positives
- The investment by Intracoastal Capital LLC, a Delaware limited liability company, indicates a vote of confidence in Iveda Solutions, Inc.'s future prospects.
- The structured acquisition of shares through a Securities Purchase Agreement and warrants suggests a strategic investment by the Reporting Persons.
Negatives
- The presence of blocker provisions in the warrants limits the immediate potential for the Reporting Persons to increase their beneficial ownership beyond certain thresholds (4.99% or 9.99%), which could cap their influence or future accumulation without further disclosures.
- The filing itself does not provide operational or financial performance details, making it difficult to assess the company's current health or the direct impact of this investment on its business.
Risks
- Dilution Risk: The issuance of 5,259,999 shares of Common Stock at the closing of the SPA transaction, along with shares issuable upon warrant exercises, could dilute the ownership percentage of existing shareholders.
- Control Limitations: Blocker provisions in the warrants prevent the Reporting Persons from exceeding certain beneficial ownership thresholds (4.99% or 9.99%), thereby limiting their ability to exert significant control or influence over the issuer's strategic direction.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that a Schedule 13G filing indicates a passive investment by a significant shareholder or group, suggesting confidence in the company's long-term prospects without an immediate intent to influence control. For Iveda Solutions, this filing highlights a new institutional investor taking a notable, albeit non-controlling, stake, which can be viewed positively by the market as a validation of the company's value proposition.
Stakeholder Impact
- Shareholders: Existing shareholders experienced dilution from the shares issued under the SPA and warrant exercises. The entry of a new institutional investor may be perceived as a positive signal for the company's valuation.
- Company Management: The company has secured capital through the SPA and warrant issuances, which could support ongoing operations or fund future growth initiatives.
Key Dates
| Date | Description |
|---|---|
| 02/09/2026 | Date of event requiring filing, specifically the execution of the Securities Purchase Agreement (SPA) with Iveda Solutions, Inc. |
| 02/11/2026 | Date of Form 424B4 prospectus filing by Iveda Solutions, Inc. disclosing the SPA. |
| 02/13/2026 | Close of business date for beneficial ownership calculation and the filing date of this Schedule 13G. |
Recommendation
holdThe filing indicates a new institutional investor, Intracoastal Capital LLC, has taken a 4.99% stake in Iveda Solutions, Inc. This suggests a degree of confidence in the company's prospects. However, the investment is passive, and the presence of blocker provisions limits immediate influence. While the capital raise is positive for the company's funding, the associated dilution warrants a 'hold' recommendation until further operational or financial performance details are available to assess the impact of this capital.
Keywords
Iveda Solutions, Intracoastal Capital, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Investment, Shareholder, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.